Cirrhosis is not a predictor of response with interferon and ribavirin retreatment of hepatitis C.

被引：0
|
作者：
Waters, B [1 ]
Ismail, MK [1 ]
Fleckenstein, JF [1 ]
Zua, MS [1 ]
Smith, JL [1 ]
Bockhold, KM [1 ]
Riely, CA [1 ]
机构：
[1] Univ Tennessee, Memphis, TN USA
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0476
引用
收藏
页码：A1287 / A1287
页数：1
相关论文
共 50 条
  • [31] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Yee, Helen S.
    Currie, Sue L.
    Tortorice, Kathryn
    Cozen, Myrna
    Shen, Hui
    Chapman, Summer
    Cunningham, Fran
    Monto, Alexander
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2439 - 2448
  • [32] Retreatment of standard interferon/ribavirin non-responder patients with chronic hepatitis C with daily consensus interferon and ribavirin yields high sustained response rates.
    Kaiser, S
    Hass, HG
    Gregor, M
    HEPATOLOGY, 2003, 38 (04) : 276A - 276A
  • [33] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Helen S. Yee
    Sue L. Currie
    Kathryn Tortorice
    Myrna Cozen
    Hui Shen
    Summer Chapman
    Fran Cunningham
    Alexander Monto
    Digestive Diseases and Sciences, 2011, 56 : 2439 - 2448
  • [34] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [35] A preliminary study of ribavirin plus interferon in the treatment for Chronic Hepatitis C.
    Bailey, BJ
    Meyer, DL
    HEPATOLOGY, 1997, 26 (04) : 1392 - 1392
  • [36] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [37] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [38] The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C
    Cavalletto, L
    Chemello, L
    Donada, C
    Casarin, P
    Belussi, F
    Bernardinello, E
    Marino, F
    Pontisso, P
    Gatta, A
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2000, 33 (01) : 128 - 134
  • [39] Erythropoietin use for ribavirin/interferon induced anemia in patients with hepatitis C.
    Weisz, K
    Kreiswirth, S
    McMeeking, M
    Braun, J
    Tirelli, J
    Talal, AH
    Dieterich, DT
    HEPATOLOGY, 1998, 28 (04) : 288A - 288A
  • [40] Predictors of response to interferon in chronic hepatitis C.
    Mollison, L
    Totten, L
    Olynyk, J
    Greenfield, C
    Beaman, M
    HEPATOLOGY, 1998, 28 (04) : 710A - 710A
12345